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Streptococcal glycoprotein-induced tumour cell growth inhibition involves
the modulation of a pertussis toxin-sensitive G protein
J Yoshida, S Takamura, S Suzuki and M Nishio
Department ofPharmacology, Kanazawa Medical University, Uchinada, Ishikawa 920-02, Japan.
Summary We studied the mechanism of anti-tumour action of a sulphydryl glycoprotein (SAGP) purified
from an extract of Streptococcus pyogenes in vitro. SAGP rapidly inhibited the incorporation of nucleic acid
precursors into murine fibrosarcoma (Meth A) cells before it inhibited the cell growth. SAGP-induced cell
growth inhibition was diminished by incubating the cells with pertussis toxin (IAP), whereas the SAGP activity
was augmented by incubating the cells with cholera toxin (CTX). Meth A cells exposed to SAGP underwent an
increase in labelling of the a-subunit of an inhibitory guanine nucleotide-binding (Gi) protein in a subsequent
IAP-catalysed [32P]ADP ribosylation of the cell membrane fraction. Gia labelling was not increased either in
the membrane from the Meth A cells exposed to heat-inactivated SAGP or in the membrane from L929 cells
exposed to SAGP, in which growth was also unaffected. By contrast, SAGP caused no alteration in labelling
the a-subunit of stimulatory guanine nucleotide-binding (Gs) protein in a subsequent CTX-catalysed ADP
ribosylation of membrane fractions of Meth A and L929 cells. The amount of intracellular cAMP was
decreased slightly in Meth A cells incubated with SAGP. Although the precise roles of Gs protein and
adenylate cyclase in the cell growth inhibition induced by SAGP are not clear, these findings suggested that the
modulation of Gi protein is involved in such SAGP-induced cellular events as the inhibition of nucleic acid
synthesis and cell growth inhibition.
Keywords: tumour cell growth; Gi protein; streptococci; glycoprotein; pertussis toxin
In the late 1800s, William B Coley and his colleagues
described the cancer therapeutic effects of erysipelas-inducing
streptococci (Nauts et al., 1946; Rook, 1992; Starnes, 1992).
Laboratory studies on microbial products as anti-tumour
agents led to the identification of an active substance, a
lipopolysaccharide (LPS) from Gram-negative bacteria and
afterwards the discovery of tumour necrosis factor (TNF) in
serum of animals injected with Bacillus Calmette-Guerin
(BCG) and LPS (Reilly, 1953; Old, 1985). Meanwhile,
Okamoto et al. (1978) reported that Streptococcus pyogenes
showed anti-tumour activity in mice and they prepared an
anti -tumour streptococcal preparation (OK-432) from a
non-virulent Su strain of the cocci. We identified an acidic
glycoprotein (SAGP) as having anti-tumour properties, from
the Streptococcus pyogenes, Su strain (Yoshida et al., 1985).
SAGP is a glycoprotein with molecular weight of 140-150
kDa, which consists of identical subunits with a molecular
weight of 48 kDa. Kanaoka et al. (1987a) compared the in
vitro and in vivo anti-tumour activities of SAGP with those of
OK-432 and further cloned and expressed the structural gene
for SAGP in Escherichia coli (Kanaoka et al., 1987b). We
observed that SAGP inhibited the growth of some cells lines
in culture, including murine embryonic cells (BALB/3T3)
(Yoshida et al., 1987), murine leukaemic L1210 (Yoshida et
al., 1989), murine fibrosarcoma Meth A (Yoshida et al.,
1991) and human HL60 (unpublished data). SAGP also
prolonged the life span of mice inoculated with Ehrlich
ascites carcinoma cells or Meth A cells. As this effect of
SAGP on the mice inoculated with these tumour cells was
reduced when they were immunosuppressed by X-irradiation
or with carrageenan, an anti-macrophage agent, host-
mediated mechanisms were thought to be involved partly in
the anti-tumour action of SAGP (Yoshida et al., 1991).
Furthermore, the studies on the SAGP-induced cell growth
inhibition using thiol reactive agents suggested that SH
groups on SAGP are involved in the anti-tumour action of
SAGP (Yoshida et al., 1994). The observation suggested that
SAGP interacts with an unknown receptor on the target cells
through its SH groups, and the signals elicit cell growth
inhibition through intracellular transduction pathways. To
clarify this assumption, we studied first the effect of SAGP on
macromolecular synthesis in the target cells, and studied
further whether or not inhibitors of several intracellular
pathways affect SAGP activity. We found that the anti-
tumour activity of SAGP on Meth A cells was modified by
first exposing the cells to a bacterial toxin, pertussis toxin
(IAP) or cholera toxin (CTX). We report here evidence
suggesting that guanine nucleotide-binding proteins are
involved in the cell growth-inhibitory action of SAGP.
Materials and methods
Preparation of SAGP
SAGP was prepared as described previously (Yoshida et al.,
1985, 1994). In brief, Streptococcus pyogenes (Su strain) cells
grown in 60 1 of Wood and Gunsalus broth were collected by
centrifugation and washed with 10 mM Tris-HCI buffer
containing 10 mM magnesium acetate, pH 7.5 (buffer A). The
cells were mechanically disrupted using a Vibrogen cell mill
(Edmund Buihler, Tiubingen), extracted with buffer A, then
centrifuged twice at 17 500 g for 20 min and once at 105000 g
for 2 h. The supernatant (CE) was heated (45°C, 30 min)
precipitated with streptomycin, fractionated with ammonium
sulphate (55-70%) and separated by sequential column
chromatography on octyl-Sepharose CL-4B, DE-52 and
Sephadex G-200. The anti-tumour activity of each chromato-
graphic fraction was evaluated by the in vitro growth
inhibition test using transformed hamster embryonic lung
(THEL) (Yoshida et al., 1985) or L1210 cells. The active
fraction from Sephadex G-200 gel filtration was dialysed
against distilled water, and the precipitate was removed. The
dialysate (SAGP, Figure 1) was stored at -20°C until use.
The protein concentration of SAGP was determined using the
BCA protein assay reagent (Pierce Chemical Company,
Rockford, I1, USA). In this report the doses of SAGP are
expressed as the weight of protein per millilitre of SAGP.
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Figure 1 Purified SAGP on sodium dodecyl sulphate (SDS)-
polyacrylamide gel. SAGP (0.5 ,ug protein) was resolved by SDS-
gel electrophoresis in a 10% polyacrylamide gel. The gel was
stained with Commassie brilliant blue. Arrow indicates SAGP
with a minimal molecular weight of 48 kDa. SP; standard
proteins.
Materials
Methyl[3H] thymidine (specific activity 1480 GBq mmol-')
and [3H] uridine (specific activity 1110 GBq mmol-') was
purchased from Amersham International (Little Chalfont,
Buckinghamshire, UK). [32P]NAD [nicotinamide adenine
(adenylate-32P) dinucleotide; specific activity; 29.6 TBq
mmol-'] was obtained from DuPont-New England Nuclear
(Wilmington, DE, USA). Pertussis toxin (lAP) and cholera
toxin (CTX) were obtained from Seikagaku (Tokyo, Japan)
and Calbiochem (La Jolla, CA, USA) respectively. The
cAMP enzyme immunoassay (EIA) system was purchased
from Amersham International.
Cell line
The murine fibrosarcoma Meth A cell line (Meth A) was used
as the target, as SAGP inhibited the growth of the cells in
vitro and also prolonged the life span ofmice inoculated with
the cells. Meth A cells were maintained in suspension culture
with Eagle's minimal essential medium containing 10% fetal
calf serum, 0.292 g 1-' L-glutamine, 12.7 mM Hepes, 1.2 g 1-'
sodium bicarbonate, 100Uml-' penicillin G and 100 Mgml-'
streptomycin under humidified 5% carbon dioxide and 95%
air at 37'C. NCTC clone 929 cell line (L929), which was
supplied by Japanese Cancer Research Resources Bank, was
used as another target cell line. L929 cells were maintained
routinely in Eagle's minimal essential medium containing
10% horse serum, L-glutamine, Hepes, sodium bicarbonate,
penicillin G and streptomycin. The cells growing exponen-
tially as a monolayer were detached by incubation with
0.02% EDTA and 0.05% trypsin at 37°C for 5 min.
Determination of cell growth-inhibitory activity
Meth A and L929 cells were seeded in 24-well culture plates
at 5 x 104 (1 ml) and 1 x 105 cells per well (1 ml) respectively.
SAGP was added immediately into the Meth A cell. L929
cells were incubated for 5 h, allowed to adhere to the bottom
of the wells, then exposed to SAGP. Following an additional
72 h incubation, the number of cells was determined by
trypan blue exclusion. The cell growth rate (percent growth
rate) was expressed as a percentage of the number of cells in
the wells with, to that without SAGP (control).
Incorporation of nucleic acid precursors into Meth A cells
Meth A cells were seeded in 96-microwell culture plates at
2 x 104 cells per well (0.2 ml) and incubated in the presence of
SAGP for a defined period (as indicated). Thereafter, 3.7 kBq
methyl [3H]thymidine or 7.4 kBq [3H]uridine in 10 Ml of
phosphate-buffered saline (PBS) was added to each well and
incubated for 3 h. The cells were then harvested on glass fibre
filters and washed extensively using an automated cell
harvester (LM 101, LaboMash, Labo Science, Tokyo,
Japan). The filters were dried and placed in a scintillation
vial containing 2 ml of scintillation fluid [5 g DPO (2,5-
diphenyloxazole) and 0.3 g POPOP (1,4-bis[2-(5-phenylox-
azolyl)]benzene) in 11 of toluene], and the radioactivity was
measured with an Aloka LSC-3600 liquid scintillation
spectrometer. All cultures were studied in triplicate. The
degree of incorporation of radioactive precursors was
expressed as a percentage of d.p.m. in the cells incubated
with, as opposed to without SAGP (control).
IAP and CTX-catalysed [32P]ADP ribosylation
Target cells (4 to 5 x 105 cells ml-' of medium per well) were
incubated in the presence and absence of SAGP for 24 h at
37°C. The cells were washed twice with PBS, then lysed in 0.2
ml of 10 mM Hepes pH 7.4, containing 10 mM EDTA.
Membrane fractions obtained as pellets in 1.5 ml micro-
centrifuge tubes by centrifugation at 8000 g for 2 min, were
washed twice with PBS and resuspended in 20 pl of the same
buffer. IAP (200 ,ug ml-') and CTX (1 mg ml-') were
activated by incubation at 37°C for 30 min with an equal
volume of 50 mM Tris-HCl (pH7.4) containing 20 mM
dithiothreitol (DTT) and 2 mM ATP and 100 mM Tris-HCI
(pH 7.4) containing 80 mM DTT respectively. For IAP-
catalysed ADP ribosylation, 10 M1 ofreaction mixture (25 mM
Tris-HCl, 35 mM thymidine, 3 mM ATP, 0.35 mM NADP, 35
mM isoniazide, 35 mM arginine, 20 gM NAD and 3.7 kBq of
[32P]NAD, pH 7.4) and 0.5 Mg of activated IAP in 5 jul were
added to the microcentrifuge tubes containing membrane
preparations. For CTX-catalysed ADP ribosylation, 10 Ml of
reaction mixture (300 mM potassium phosphate, 150 mM
sodium chloride, 4 mM EDTA, 40 mM thymidine, 4 gM
NAD, 0.1 mM NADP, 10 mM isoniazide, 2.5 mm magnesium
chloride and 0.74 kBq of [32P]NAD, pH 7.4) and 2.5 Mg of
activated CTX in 5 Ml were added to the microcentrifuge
tubes. These mixtures were incubated for 60 min at 37°C,
then the reaction was stopped by centrifugation at 8000 g for
2 min. The pellet w^as washed twice with ice-cold PBS,
solubilised in 40 Ml of 8 mm Tris-HCl containing 1.6% (w/v)
sodium dodecyl sulphate (SDS), 16% glycerol and 10% (v/v)
mercaptoethanol and 0.05% (w/v) bromphenol blue, pH 6.8,
then heated at 94°C for 5 min. The proteins (30 Ml) were
separated by SDS-polyacrylamide gel electrophoresis accord-
ing to Laemmli (1970) using 10% polyacrylamide gels. The
gels were stained with Coomassie brilliant blue (Quick-CBB;
Wako Pure Chemical Industries, Tokyo, Japan), destained,
dried and exposed to X-ray film (Kodak XAR-5; Eastman
Kodak Company, NY, USA) at -80°C.
Measurement of cAMP
Meth A cells (7-8 x 105 cells) were incubated with 3.5-4 ml
of medium in plastic plates (3.5 cm diameter) in the presence
and absence of SAGP. After 24 h, an aliquot of the cell
suspension was sampled and the cell viability was determined
by trypan blue exclusion. The cultures (3.0 ml) were
centrifuged at 2000 g for 5 min and the cell pellets wereTumour cell growth inhibition by streptococcal glycoprotein
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washed once with 5 ml ofcold PBS. The cAMP was extracted
with ethanol as follows: 2 ml of cold 65% (v/v) ethanol was
added to the washed cell pellets, mixed with vortex mixer and
centrifuged at 2000 g for 10 min. The supernatant was
decanted into a test tube for evaporation. The remaining
precipitate was processed again in the same manner and the
second extract was added to the first. The total extract was
dried in a vacuum oven at 60'C. Dried extracts were stored
at -20°C until cAMP assay with an EIA system according
to the manufacturer's instructions.
Statistical analysis
The data were analysed using the program package 'StatView
IV' (Abacus Concepts, Berkeley, CA, USA) as indicated in
the figures. P-values below 0.05 were considered significant.
Results
Effects of SAGP on the cell growth
We showed previously that SAGP inhibits the growth of
Meth A cells in vitro in a concentration-dependent manner
(Yoshida et al., 1991). In this study, we have shown that the
growth of L929 cells is not affected by 0.1 to 3 Mg ml-' of
SAGP (Figure 2). Even at higher doses of SAGP (up to 100
jg ml-'), the growth of L929 cells was not affected (data not
shown). We then used L929 as a cell line insensitive to SAGP
in some experiments. Figure 3 shows the time course of the
effect of SAGP on the growth of Meth A cells. When 0.1 uMg
ml-' SAGP was added to Meth A on day 0, the growth-
inhibitory effect of SAGP was apparent on day 2 and
gradually increased on days 3 and 4. When SAGP was
removed from the culture medium on day 2 by washing the
cells by centrifugation, the cells were grown again as control
cultures. These results indicated that the growth inhibition of
Meth A cells by SAGP was reversible and time dependent.
Effects ofSAGP on the incorporation ofnucleic acidprecursors
into Meth A cells
Figure 4a shows that SAGP reduced the incorporation of
two radioactive nucleic acid precursors [3H]thymidine and
[3H]uridine into Meth A cells in a concentration-dependent
manner over 16 h. As shown in Figure 4b, SAGP inhibited
the [3H]thymidine incorporation into Meth A cells in a time-
dependent manner. SAGP at a concentration of 1.0 Mg ml-'
.R 9,
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significantly reduced the [3H] thymidine incorporation during
the first 2 h. These results indicated that the inhibitory effects
of SAGP on nucleic acid synthesis preceded the growth
inhibition by SAGP.
Effects ofIAP and CTX on the cell growth-inhibitory action of
SAGP
Figure 5 shows that the growth-inhibitory effect of SAGP on
Meth A cells was diminished by first incubating the cells with
IAP. When the cells were incubated with 1-100 ng ml - of
IAP for 24 h, then for 72 h in the presence of 0.1 or 0.3 Mg
ml-' SAGP, the effect of SAGP was slightly but significantly
diminished compared with that in the control cells. By
contrast, the growth-inhibitory effect of SAGP was
significantly augmented in the cells that were incubated with
0.3-3.0 Mg ml-' CTX for 24 h beforehand (Figure 6).
Effects of SAGP on IAP and CTX-catalysed ADP
ribosylation
Meth A or L929 cells were incubated with the indicated
concentrations of SAGP or 100 ng ml-' IAP for 24 h. The
cell membrane fractions were ADP-ribosylated with activated
IAP and [32P]NAD as described in Materials and methods.
Figure 7 shows autoradiograms of SDS-polyacrylamide gel of
cell membrane fractions after IAP-catalysed ADP ribosyla-
tion. SAGP caused an increase in the IAP-catalysed ADP
ribosylation of the membrane protein from Meth A cells,
with a molecular weight of 41 kDa. Densitometric scanning
(Shimadzu CS-9000, Kyoto, Japan) revealed that the intensity
of labelling for 41 kDa protein in membrane fraction from
the cells incubated with 0.3, 1.0, 3.0 and 10.0 Mg ml-' SAGP
were 97, 170, 200 and 220% of control respectively. The
intensity of Coomassie brilliant blue staining of the 41 kDa
protein was similar for each lane (data not shown). By
contrast, previous exposure to SAGP caused no increase in
the IAP-catalysed ADP ribosylation of the 41 kDa protein in
L929 cells. There was no labelled band in the membrane
fractions from Meth A cells or L929 cells initially incubated
with IAP (100 ng ml-'), which indicated that the labelled 41
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Figure 2 The effects of SAGP on cell growth in vitro.
Meth A - 0 - (5 x 104 cells ml-') and L929 -_* (1 x 105 cells
ml-') were incubated with 0.03-3.0 Mig ml-' SAGP for 72h
respectively. The data are the means + s.e. offour cultures of two
separate experiments for L929 cells and of six cultures of three
separate experiments for Meth A cells.
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Figure 3 The time course of the effect of SAGP on Meth A cell
growth. Meth A cells (5 x 104 cells ml-) were incubated in the
absence (-0-) and presence (-0 -) of 0.1jIg ml-l SAGP for 4
days. On day 2, SAGP was removed from the culture by washing
the cells by centrifugation and the cells were incubated in fresh
medium without SAGP (-O -). The data are the means+s.e. of
eight cultures of four separate experiments.
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Figure 5 The effect of pertussis toxin (IAP) on SAGP-induced
cell growth inhibition. Meth A cells (5 x104 cells ml-') were
incubated with 1-100 ng ml-l IAP for 24h, then with 0.0 (E]),
0.1 () or 0.3 ( ,ug ml- SAGP for 72h. The data are the
means+s.e. of six cultures of three separate experiments.
Interactions between the variables of IAP and SAGP-addition
were regarded as significant by the two-way analyses of variance
(ANOVA). Statistical analyses of the variables of the groups
incubated with IAP, IAP and SAGP (0.1 jIg ml-l), and IAP and
SAGP (0.3 ,ig ml-'), were performed by one-way ANOVA
followed by Sheffe's F (*P<0.05).
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Figure 4 (a) The inhibitory effects of SAGP on the incorporation
of [3H]thymidine (-0-) and [3H]uridine (- -) into Meth A
cells. Meth A cells (1 x 105 cells ml-1) were incubated with 0.03-
3.0 ,ig ml-' SAGP for 16h, followed by a pulse with
[3H]thymidine or [3H]uridine for 3h. Incorporation is expressed
as a percentage of the d.p.m. in the control cells. The data are the
means+s.e. of 3-4 separate experiments. (b) The time course of
incorporation (%) of [3H]thymidine into Meth A cells. Meth A
cells (1 x 105 cells ml-') were incubated with 0.03 (---), 0.1
(-*-) and 1.0 ( * ) jiM ml-' SAGP for 2, 4, 6 and 24h
followed by a pulse with [ H]thymidine for 3 h. Incorporation is
expressed as a percentage of d.p.m. in the control cells. The data
are the means+s.e. of three separate experiments.
kDa membrane protein was a substrate for IAP, namely the
a-subunit of inhibitory GTP-binding protein (Gia).
On the other hand, Meth A or L929 cells were incubated
with the indicated concentrations of SAGP, 100 ng ml-' IAP
or 1 jug ml-l CTX for 24 h. The cell membrane fractions
were prepared and ADP-ribosylated with activated CTX and
[32P]NAD. Autoradiograms of SDS-polyacrylamide gel of the
membranes show that two membrane proteins, 47 and 45
kDa, in Meth A cells and only one (47 kDa), in L929 cells
were ADP ribosylated in the presence of CTX (Figure 8).
These labelled bands were not observed in the membrane
fractions from the cells initially exposed to CTX (1 ,ig ml-'),
indicating that these proteins correspond to CTX substrates,
the a-subunit of stimulatory GTP-binding protein (Gsa). As
shown in Figure 8, CTX-catalysed ADP ribosylation did not
alter the intensity of Gsa labelling in the membrane fractions
' 80
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Figure 6 The effect of cholera toxin (CTX) on SAGP-induced
cell growth inhibition. Meth A cells (5 x104 cells ml-') were
incubated with 0.3-3.0 jig ml-l CTX for 24h, then with 0.0 (Oa),
0.03 (M) or 0.1 (_) ,ig ml-1 SAGP for 72h. The data are the
means+ s.e. of six cultures of three separate experiments.
Interactions between the variables of CTX and SAGP addition
were regarded as significant by two-way ANOVA. Statistical
analyses of the variables of the groups incubated with CTX, CTX
and SAGP (0.03 Mg ml-1), and CTX and SAGP (0.1 jIg ml-1),
were performed by one-way ANOVA followed by Sheffe's F
(*P <0.05).
from either Meth A or L929 cells incubated with SAGP. This
suggested that SAGP did not modify Gsa availability for the
CTX-catalysed ADP ribosylation.
Figure 9 shows that the IAP-catalysed ADP ribosylation
of Gia was increased in membranes from Meth A cells
incubated with SAGP, but not with heat (94°C for 30 min)-
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Figure 7 Autoradiograms of pertussis toxin (IAP)-catalysed ADP ribosylation of Meth A and L929 cell membrane fractions. Meth
A and L929 cells were incubated in the absence (control) or presence of 100 ng ml- 1 IAP (IAP) or 0.3 -10.0 ig ml-F' SAGP [SAGP
(0.3)-(10)] for 24h. The cell membrane fractions were isolated and IAP-catalysed ADP ribosylation was studied as described in
Materials and methods. The molecular mass markers (Bio-Rad) were phosphorylase B (97.4 kDa), bovine serum albumin (66.2
kDa), ovalbumin (45 kDa), and carbonic anhydrase (31 kDa). Similar results were obtained in three other experiments.
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Figure 8 Autoradiograms of cholera toxin (CTX)-catalysed ADP ribosylation of Meth A and L929 cell membrane fractions. Meth A and
L929 cells were incubated in the absence (control) or presence of 1 jig ml-l CTX (CTX), 100 ng ml-l IAP (IAP) or 1, 10 mg ml-l SAGP
[SAGP (1), (10)] for 24h. The cell membrane fractions were isolated and CTX-catalysed ADP ribosylation was studied as described in
Materials and methods. Similar results were obtained in three other experiments.
inactivated SAGP. SAGP incubated for 30 min at 94°C had
no growth-inhibitory effect on Meth A cells (data not
shown).
Effect of SAGP on intracellular cAMP levels
The above experiments suggested that the IAP-sensitive GTP-
binding protein is involved in SAGP-induced Meth A cell
growth inhibition. To examine whether or not the GTP-
binding protein is functionally related to adenylate cyclase,
we measured the intracellular cAMP contents of Meth A cells
exposed to SAGP. Meth A cells (2 x I05 cells ml-') were
incubated in the absence or presence of 0.1 to 3.0 Mg ml-' of
SAGP for 24 h, or with 1 Mg ml - CTX or 100 ng ml- I AP
as positive controls. The numbers (per cent growth rate) in
the controls and in the presence of 0.1, 0.3, 1.0 and 3.0 Mg
ml-' SAGP, were 5.1 x 105 (100), 5.1 x 105 (100), 3.1 x105
(60.8), 2.7 x 105 (52.9) and 2.45 x 105 cells ml-' (48.0)
respectively. The numbers (percent growth rate) in the plates
containing CTX and IAP were 4.4 x 105 (86.3) and 5.8 x 105
cells ml-' (113.7) respectively. Figure 10 shows the cAMP
contents in each culture as fmol 10-5 cells. Exposure of Meth
A cells to CTX caused a 2.5-fold increase in cAMP level,
whereas exposure of the cells to IAP did not cause significant
accumulation of cAMP. In contrast, the cAMP level in the
cells exposed to SAGP was reduced slightly with increasing
concentrations of SAGP (Figure 10).
Discussion
The growth-inhibitory effect of SAGP on Meth A cells was
reversible and time dependent (Figure 3). SAGP retarded cell
proliferation within 1-2 days. On the other hand, SAGP
reduced the incorporation of two nucleic acid precursors into
Meth A cells within 24 h in a concentration-dependent
manner (Figure 4a and b). These results suggested that the
inhibition of nucleic acid synthesis by SAGP may precede the
cell growth inhibition. In a recent paper we showed that SH
groups on SAGP may be involved in the anti-tumour action
of SAGP, as thiol-reactive agents such as cystamine and
DTNB [5,5'dithiobis(2-nitrobenzoic acid)] diminished its
activity (Yoshida et al., 1994). These findings indicate that
SAGP interacts with an unknown receptor or acceptor on
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Figure 9 Autoradiogram of IAP-catalysed ADP ribosylation of
the membrane fractions from Meth A cells incubated with heat-
inactivated SAGP. Meth A cells were incubated in the absence
(control) or presence of 100 ng ml-'IAP (IAP), 1, 3 Mg ml-1
SAGP [SAGP(1), (3)] or 1, 3 ,ug ml-' of heat-inactivated SAGP
[inactivated SAGP (1), (3)] for 24h. The cell membrane fractions
were isolated and IAP-catalysed ADP ribosylation was studied as
described in Materials and methods.
target cells through the SH groups on SAGP and that a
signal produced by the interaction might be conducted
through an intracellular pathway. This signal might elicit
the inhibition of synthesis of nucleic acids and inhibit cell
proliferation.
Studies of inhibitors of several intracellular pathways
revealed that the growth-inhibitory action of SAGP on Meth
A cells was altered in cells incubated with IAP or CTX. The
activity of SAGP was diminished in cells exposed to IAP
beforehand (Figure 5), but augmented by CTX (Figure 6).
IAP catalyses ADP ribosylation of a cysteine residue in the a-
subunit of inhibitory GTP-binding (Gi) protein, and thereby
blocks interactions between Gi protein and receptors (Katada
and Ui, 1982; Murayama and Ui, 1983). On the other hand,
CTX activates stimulatory GTP-binding (Gs) protein by
ADP-ribosylating an arginine residue of the a-subunit in Gs
protein (Northup et al., 1980; Hepler and Gilman, 1992). The
finding that the activity of SAGP was diminished by IAP
suggested the involvement of Gi protein in the expression of
SAGP activity.
Accordingly, to investigate the activity of G-protein, we
examined the ability of SAGP to modify the IAP or CTX-
catalysed ADP ribosylation. The IAP-catalysed ADP
ribosylation assay showed that SAGP caused an increase in
labelling of the 41 kDa protein of Meth A membrane (Figure
7). Since IAP catalyses ADP ribosylation of the a-subunit of
heterotrimeric Gi protein (Katada et al., 1986), the increase
in labelled Gia indicated that SAGP may induce an
abundance of heterotrimeric Gi protein or increase the
susceptibility of Gia to ADP ribosylation by IAP. SAGP
did not cause such an increase in labelled 41 kDa protein of
L929 cells, which were SAGP insensitive in respect of growth
inhibition (Figure 7). In addition, the increase in the labelled
protein was not detected in Meth A cells incubated with heat
(94°C, 30 min)-inactivated SAGP (Figure 9). On the other
hand, there was no modification in the CTX-catalysed ADP
ribosylation of Gsa in the membranes from either Meth A or
L929 cells incubated with SAGP (Figure 8). That is, ADP
ribosylation was only altered in the presence of IAP but not
Figure 10 The effect of SAGP on intracellular cAMP levels.
Meth A cells (2 x 105 cells ml-1) were incubated with 0.1-3.0 ig
ml-n SAGP, 100 ng ml-KIAP or 1 yg ml-n CTX for 24h. The
cAMP contents were determined as described in Materials and
methods. The data are the means+ s.e. of six determinations of
two separate experiments. The statistical analyses of the variables
of the groups incubated with SAGP were performed by one-way
ANOVA followed by Sheffe's F. Statistical analyses between
control and IAP or CTX groups were performed by unpaired
Student's t-test (*P< 0.05).
CTX, and the increase in the IAP-catalysed ADP ribosylation
of 41 kDa protein corresponding to Gia seemed to be
associated with the biologically active state of SAGP.
Agarwal et al. (1988) have shown that TNF-mediated
cytotoxicity involves ADP ribosylation. TNF caused an
increase of [3H]ADP ribose incorporation into L929 cells
parallel to the rate of cell death, and an inhibitor of ADP
ribosylation, 3-aminobenzamide (3ABA) prevented TNF-
mediated cytotoxicity. We failed to detect an effect of
3ABA on SAGP-induced cell growth inhibition, as 3ABA
was cytotoxic to Meth A at 10 mM, the concentration that
inhibited ADP ribosylation. Imamura et al. (1988) reported
that TNF induced the stimulation of GTP binding to cell
membrane preparations from HL-60 and L929 cells, and the
effect was associated with an increase in GTPase activity. In
addition, they showed that IAP inhibited the TNF-induced
increase in GTPase activity in HL-60 cells membranes and
also the TNF-induced cytotoxicity to L929 cells, suggesting
the involvement of IAP-sensitive GTP-binding protein in the
action of TNF. We found that the growth-inhibitory effect of
SAGP was diminished in cells first incubated with IAP and
that SAGP specifically caused an increase in Gia protein
labelling by IAP-catalysed ADP ribosylation. These findings
suggested that IAP-sensitive Gi protein is involved in the
expression of the SAGP activity.
We measured the intracellular cAMP contents of Meth A
cells after exposure to SAGP to investigate whether or not
the effects of SAGP on Gi protein are associated with
modulation of adenylate cyclase. The cAMP level of these
cells was slightly reduced (Figure 10). This does not
contradict the assumption that SAGP activates Gi protein
and hence reduces the intracellular cAMP level. The effect of
SAGP on cAMP levels was rather small, whereas CTX
caused a higher and reproducible elevation of the cAMP level
owing to activation of the Gs protein. In addition, there was
no significant difference between the cAMP level in the cells
incubated with CTX alone and those treated with CTX plus
SAGP (data not shown). At present, there is no direct
evidence linking the reduction in the cAMP level to the cell
growth-inhibitory action of SAGP. Other effector enzymes in
the intracellular transduction system such as phospholipase C
and phospholipase A2, which are associated with Gi protein
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(Hepburn et al., 1987; Gilman, 1987; Kurachi et al., 1989;
Birnbaumer et al., 1990; Bourne et al., 1990; Spriggs et al.,
1990; Nakahata et al., 1991), might be linked to the Gi
protein modulated by SAGP.
At present, we do not know why the SAGP activity was
augmented by CTX in Meth A cells. As Kahn and Gilman
(1984) pointed out, ADP ribosylation of Gs promotes the
dissociation of its a- and fly-subunits. The fly-subunits of Gs
share identity with those ofGi (Gilman, 1984, 1987) and play
practical roles in transmembrane signal cascades (Neer and
Clapham, 1988; Birnbaumer et al., 1990; 1992). Therefore,
the continuous stimulation of Gs protein by CTX might
induce an alteration of LAP-sensitive G-protein or effector
molecules linked to the G-protein through its dissociated fly-
subunits. It is possible that there is a mutual regulation
between different G-protein-mediated signal pathways. In
addition, in the examination of CIX-catalysed ADP
ribosylation (Figure 8), two bands of 45 and 47 kDa (Gsax)
were detected in Meth A cell membrane; these two bands
most likely represent the long- and short-splice variants of
Gs, whereas only a single band of 47 kDa was present in
L929 cell membrane. Furthermore, CIX-catalysed ADP
nrbosylation seems to increase in the membrane of Meth A
cells incubated with LAP (the third lane to the left) as
compared with that of control cells, whereas such an effect
was not apparent in L929 cell membrane. The difference in
responsiveness of Meth A and L929 cells to CTX-catalysed
ADP ribosylation may be caused by a difference in their
sensitivity to SAGP and the enhanced effect of CTX on the
SAGP-induced growth inhibition on Meth A cells. More
extensive studies are required to test this hypothesis.
Although, our interpretation of the results of the CTX and
CTX-catalysed ADP ribosylation assay remains speculative,
it is intresting to note that CTX augmented an external
signal effect that was inhibited by IAP.
In conclusion, our findings provide the first evidence that
an TAP-sensitive GTP-binding protein is involved in the cell
growth-inhibitory action of SAGP. SAGP may be useful for
the investigation of the signal transduction pathways in cell
proliferation, and may be a novel bacterial anti-tumour
glycoprotein in cancer therapy because of its immunomodu-
lating and cell growth-inhibitory effects.
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